Dr. Xu holds a Master's degree and currently serves at the Microbiology Laboratory of the First Affiliated Hospital, Zhejiang University School of Medicine. She has extensive expertise in precise identification of clinical pathogens and antimicrobial susceptibility testing analysis. 

Her research interests focus on virulence, antimicrobial resistance, and transmission mechanisms of clinical pathogens. As a Principal investigator, she leads one project funded by the National Natural Science Foundation of China (NSFC). 

She has published 10 SCI-indexed papers as first or corresponding author.

Clinical microbiology testing

Identification of common and rare pathogens

Analysis and interpretation of antimicrobial susceptibility results

Etiological diagnosis support

Guidance on rational and personalized antimicrobial therapy

Principal Investigator of the National Natural Science Foundation of China project: "The mechanism of MMR inactivation facilitates bla_KPC mutations under the selective pressure of ceftazidime/avibactam."

Published 6 SCI-indexed papers in the past 5 years (5 as first author, 1 as corresponding author), including 2 with impact factor > 10.

Xu M, Zhao J, Xu L, Yang Q, Xu H, Kong H, Zhou J, Fu Y. Emergence of transferable ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae due to a novel CMY AmpC β-lactamase in China. Clin Microbiol Infect 2022; 28(1):136 e131-136 e136.

Min Xu,Yiqi Fu,Yuchao Zhang,Haishen Kong,Wenxin Zhao,Haiyan Zeng，Emergence of transferable aztreonam-avibactam resistance in the high-risk ST44 subclade of carbapenemase-producing Providencia hangzhouensis, 2012-2023，J Infect, Aug;91(2):106562.

Min Xu, Yuchao Zhang, Yajie Fu, Qiaoling Sun, Haishen Kong, Yiqi Fu, Evaluation of EUCAST rapid antimicrobial susceptibility testing (RAST) for carbapenemase-producing Klebsiella pneumoniae with focus on KPC variants, Eur J Clin Microbiol Infect Dis, 2025 Dec;44(12):3079-3086.

Min Xu, Xiaofen Mo, Yuchao Zhang, Huinan Xia, Huiqiong Jia, Haishen Kong, Qixia Luo, Yiqi Fu, Epidemiological and genetic profiles of ceftazidime/avibactam-resistant Klebsiella pneumoniae conferred by KPC variants in a tertiary hospital in China, J Glob Antimicrob Resist, 2025 Dec:45:176-181.

Yiqi Fu, Yuchao Zhang, Jun Zhao, Jiahong Xie, Haishen Kong, Tingting Yang, Wei Chen, Min Xu, Emergence of co-resistance to imipenem/relebactam and ceftazidime/avibactam in clinical Klebsiella pneumoniae ST11 clone due to KPC-2 N132S and CTX-M-65 S130G/P167S substitutions, Antimicrob Agents Chemother, 2025 Dec 10;69(12):e0089125.